BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 10913312)

  • 1. Role of calnexin, calreticulin, and endoplasmic reticulum mannosidase I in apolipoprotein(a) intracellular targeting.
    Wang J; White AL
    Biochemistry; 2000 Aug; 39(30):8993-9000. PubMed ID: 10913312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of interactions of sendai virus envelope glycoproteins, F and HN, with endoplasmic reticulum-resident molecular chaperones, BiP, calnexin, and calreticulin.
    Tomita Y; Yamashita T; Sato H; Taira H
    J Biochem; 1999 Dec; 126(6):1090-100. PubMed ID: 10578061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential interaction of coagulation factor VIII and factor V with protein chaperones calnexin and calreticulin.
    Pipe SW; Morris JA; Shah J; Kaufman RJ
    J Biol Chem; 1998 Apr; 273(14):8537-44. PubMed ID: 9525969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calnexin and calreticulin promote folding, delay oligomerization and suppress degradation of influenza hemagglutinin in microsomes.
    Hebert DN; Foellmer B; Helenius A
    EMBO J; 1996 Jun; 15(12):2961-8. PubMed ID: 8670797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presecretory degradation of apolipoprotein [a] is mediated by the proteasome pathway.
    White AL; Guerra B; Wang J; Lanford RE
    J Lipid Res; 1999 Feb; 40(2):275-86. PubMed ID: 9925657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of N-linked glycosylation results in retention of intracellular apo[a] in hepatoma cells, although nonglycosylated and immature forms of apolipoprotein[a] are competent to associate with apolipoprotein B-100 in vitro.
    Bonen DK; Nassir F; Hausman AM; Davidson NO
    J Lipid Res; 1998 Aug; 39(8):1629-40. PubMed ID: 9717723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rubella virus glycoprotein interaction with the endoplasmic reticulum calreticulin and calnexin.
    Nakhasi HL; Ramanujam M; Atreya CD; Hobman TC; Lee N; Esmaili A; Duncan RC
    Arch Virol; 2001; 146(1):1-14. PubMed ID: 11266204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-linked oligosaccharide processing, but not association with calnexin/calreticulin is highly correlated with endoplasmic reticulum-associated degradation of antithrombin Glu313-deleted mutant.
    Tokunaga F; Hara K; Koide T
    Arch Biochem Biophys; 2003 Mar; 411(2):235-42. PubMed ID: 12623072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of newly synthesized apolipoprotein B with calnexin and calreticulin requires glucose trimming in the endoplasmic reticulum.
    Tatu U; Helenius A
    Biosci Rep; 1999 Jun; 19(3):189-96. PubMed ID: 10513896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoplasmic reticulum (ER)-associated degradation of misfolded N-linked glycoproteins is suppressed upon inhibition of ER mannosidase I.
    Tokunaga F; Brostrom C; Koide T; Arvan P
    J Biol Chem; 2000 Dec; 275(52):40757-64. PubMed ID: 10984471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folding of insulin receptor monomers is facilitated by the molecular chaperones calnexin and calreticulin and impaired by rapid dimerization.
    Bass J; Chiu G; Argon Y; Steiner DF
    J Cell Biol; 1998 May; 141(3):637-46. PubMed ID: 9566965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of N-oligosaccharide endoplasmic reticulum processing reactions in glycoprotein folding and degradation.
    Parodi AJ
    Biochem J; 2000 May; 348 Pt 1(Pt 1):1-13. PubMed ID: 10794707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calnexin and calreticulin binding to human thyroperoxidase is required for its first folding step(s) but is not sufficient to promote efficient cell surface expression.
    Fayadat L; Siffroi-Fernandez S; Lanet J; Franc JL
    Endocrinology; 2000 Mar; 141(3):959-66. PubMed ID: 10698171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of calreticulin and calnexin during mucin synthesis in LS180 and HT29/A1 human colonic adenocarcinoma cells.
    McCool DJ; Okada Y; Forstner JF; Forstner GG
    Biochem J; 1999 Aug; 341 ( Pt 3)(Pt 3):593-600. PubMed ID: 10417322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycoprotein degradation: do sugars hold the key?
    Frigerio L; Lord JM
    Curr Biol; 2000 Sep; 10(18):R674-7. PubMed ID: 10996809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of the thyrotropin receptor with calnexin, calreticulin and BiP. Efects on the maturation of the receptor.
    Siffroi-Fernandez S; Giraud A; Lanet J; Franc JL
    Eur J Biochem; 2002 Oct; 269(20):4930-7. PubMed ID: 12383251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 6-Aminohexanoic acid as a chemical chaperone for apolipoprotein(a).
    Wang J; White AL
    J Biol Chem; 1999 Apr; 274(18):12883-9. PubMed ID: 10212277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calnexin/Calreticulin and Assays Related to N-Glycoprotein Folding In Vitro.
    Ihara Y; Ikezaki M; Takatani M; Ito Y
    Methods Mol Biol; 2020; 2132():295-308. PubMed ID: 32306337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dimerization of ER-resident molecular chaperones mediated by ERp29.
    Nakao H; Seko A; Ito Y; Sakono M
    Biochem Biophys Res Commun; 2021 Jan; 536():52-58. PubMed ID: 33360823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oligosaccharide binding characteristics of the molecular chaperones calnexin and calreticulin.
    Vassilakos A; Michalak M; Lehrman MA; Williams DB
    Biochemistry; 1998 Mar; 37(10):3480-90. PubMed ID: 9521669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.